Drug Search Results
Using advanced filters...
Advanced Search [+]

DWC-202202

Alternative Names: DWC-202202, DWC 202202, DWC202202
Latest Update: 2023-04-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Daewoong
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for DWC-202202

Countries in Clinic: Korea

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DW_DWP14012110

P1

Completed

Healthy Volunteers

2023-03-06

28%

Recent News Events

Date

Type

Title